What are the benefits of bexarotene or alemtuzumab in the treatment of cutaneous T-cell lymphoma (CTCL)?

Updated: Aug 15, 2018
  • Author: Lauren C Pinter-Brown, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Bexarotene is also sometimes used for disease confined to the skin. Beneficial effects of bexarotene and of alemtuzumab (anti-CD52) have been noted, but the long-term effects of these therapies remain to be established. [107]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!